Role of Selected miRNAs as Diagnostic and Prognostic Biomarkers in Cardiovascular Diseases, Including Coronary Artery Disease, Myocardial Infarction and Atherosclerosis
Cardiovascular diseases are the leading cause of death worldwide in different cohorts. It is well known that miRNAs have a crucial role in regulating the development of cardiovascular physiology, thus impacting the pathophysiology of heart diseases. MiRNAs also have been reported to be associated with cardiac reactions, leading to myocardial infarction (MCI) and ultimately heart failure (HF). To prevent these heart diseases, proper and timely diagnosis of cardiac dysfunction is pivotal. Though there are many symptoms associated with an irregular heart condition and though there are some biomarkers available that may indicate heart disease, authentic, specific and sensitive markers are the need of the hour. In recent times, miRNAs have proven to be promising candidates in this regard. They are potent biomarkers as they can be easily detected in body fluids (blood, urine, etc.) due to their remarkable stability and presence in apoptotic bodies and exosomes. Existing studies suggest the role of miRNAs as valuable biomarkers. A single biomarker may be insufficient to diagnose coronary artery disease (CAD) or acute myocardial infarction (AMI); thus, a combination of different miRNAs may prove fruitful. Therefore, this review aims to highlight the role of circulating miRNA as diagnostic and prognostic biomarkers in cardiovascular diseases such as coronary artery disease (CAD), myocardial infarction (MI) and atherosclerosis.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
---|---|
Enthalten in: |
Journal of cardiovascular development and disease - 8(2021), 2 vom: 19. Feb. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mir, Rashid [VerfasserIn] |
---|
Links: |
---|
Themen: |
AMI |
---|
Anmerkungen: |
Date Revised 16.03.2021 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/jcdd8020022 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM322269865 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM322269865 | ||
003 | DE-627 | ||
005 | 20231225181701.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/jcdd8020022 |2 doi | |
028 | 5 | 2 | |a pubmed24n1074.xml |
035 | |a (DE-627)NLM322269865 | ||
035 | |a (NLM)33669699 | ||
035 | |a (PII)22 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mir, Rashid |e verfasserin |4 aut | |
245 | 1 | 0 | |a Role of Selected miRNAs as Diagnostic and Prognostic Biomarkers in Cardiovascular Diseases, Including Coronary Artery Disease, Myocardial Infarction and Atherosclerosis |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 16.03.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Cardiovascular diseases are the leading cause of death worldwide in different cohorts. It is well known that miRNAs have a crucial role in regulating the development of cardiovascular physiology, thus impacting the pathophysiology of heart diseases. MiRNAs also have been reported to be associated with cardiac reactions, leading to myocardial infarction (MCI) and ultimately heart failure (HF). To prevent these heart diseases, proper and timely diagnosis of cardiac dysfunction is pivotal. Though there are many symptoms associated with an irregular heart condition and though there are some biomarkers available that may indicate heart disease, authentic, specific and sensitive markers are the need of the hour. In recent times, miRNAs have proven to be promising candidates in this regard. They are potent biomarkers as they can be easily detected in body fluids (blood, urine, etc.) due to their remarkable stability and presence in apoptotic bodies and exosomes. Existing studies suggest the role of miRNAs as valuable biomarkers. A single biomarker may be insufficient to diagnose coronary artery disease (CAD) or acute myocardial infarction (AMI); thus, a combination of different miRNAs may prove fruitful. Therefore, this review aims to highlight the role of circulating miRNA as diagnostic and prognostic biomarkers in cardiovascular diseases such as coronary artery disease (CAD), myocardial infarction (MI) and atherosclerosis | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a AMI | |
650 | 4 | |a CAD | |
650 | 4 | |a MI | |
650 | 4 | |a acute myocardial infarction | |
650 | 4 | |a cardiovascular diseases | |
650 | 4 | |a coronary artery disease | |
650 | 4 | |a miR | |
650 | 4 | |a miRNA | |
650 | 4 | |a microRNA | |
650 | 4 | |a myocardial infarction | |
700 | 1 | |a Elfaki, Imadeldin |e verfasserin |4 aut | |
700 | 1 | |a Khullar, Naina |e verfasserin |4 aut | |
700 | 1 | |a Waza, Ajaz Ahmad |e verfasserin |4 aut | |
700 | 1 | |a Jha, Chandan |e verfasserin |4 aut | |
700 | 1 | |a Mir, Mohammad Muzaffar |e verfasserin |4 aut | |
700 | 1 | |a Nisa, Shamsu |e verfasserin |4 aut | |
700 | 1 | |a Mohammad, Babar |e verfasserin |4 aut | |
700 | 1 | |a Mir, Tahir Ahmad |e verfasserin |4 aut | |
700 | 1 | |a Maqbool, Mohsin |e verfasserin |4 aut | |
700 | 1 | |a Barnawi, Jameel |e verfasserin |4 aut | |
700 | 1 | |a Albalawi, Salem Owaid |e verfasserin |4 aut | |
700 | 1 | |a Abu-Duhier, Faisel M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of cardiovascular development and disease |d 2014 |g 8(2021), 2 vom: 19. Feb. |w (DE-627)NLM248446517 |x 2308-3425 |7 nnns |
773 | 1 | 8 | |g volume:8 |g year:2021 |g number:2 |g day:19 |g month:02 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/jcdd8020022 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 8 |j 2021 |e 2 |b 19 |c 02 |